documents: FDA-2016-M-0035-0042
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-M-0035-0042 | FDA | FDA-2016-M-0035 | Reference 40 - A Cluster of Hepatitis B Infections Associated with Incorrect Use of a Capillary Blood Sampling Device in a Nursing Home in the Netherlands, 2007 re Effective Date of Requirement for Premarket Approval for Blood Lancets | Supporting & Related Material | Background Material | 2016-03-07T05:00:00Z | 2016 | 3 | 2016-03-07T16:39:26Z | 0 | 0 | 0900006481e9dac6 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref